Interestingly, VEGFA contributes to an impairment of the barrier properties of BECs in vitro, and further analyses in a rodent model of PD in mice revealed greater expression of VEGFA in astrocytes than in controls. This evidence concerns the gene VEGFA and Parkinson disease.